spacer
home > pmps > summer 2017 > track your progress
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Track Your Progress

While serialisation in the pharmaceutical supply chain is generally regarded as inevitable – counterfeiting is simply too large of a problem to not be addressed – some uncertainty around the specifics exists, particularly from a global position. Regulations are advancing at various speeds around the world, and, to date, global standards as to how serial numbers should be formatted have not emerged.

Progressing Through Uncertainty

This has demanded that manufacturers move forward cautiously in their approach to serialisation. They must take steps to prepare without committing themselves to technologies that may not support future requirements. To that end, many have placed systems necessary to apply and capture serialisation data in their packaging processes, but have, in general, not addressed the impact of tracking these numbers across the supply chain.

This is partly due to the nature of a typical pharma supply chain, which is more dependent on third-party logistics providers for downstream processes than other industries. These providers enable companies to minimise supply chain assets and focus their capital on R&D, but they tend to limit their investments in automation because short-term contracts do not allow a return on investment within the contract period.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Michiel Veenman, Global Market Leader at Swisslog Warehouse and Distribution Solutions, has worked with various pharma companies to design advanced intralogistics solutions prior to taking on his current role. As such, he is responsible for continuously improving the company’s contribution to the market. This includes market research, organisational development and training and solution design, as well as systems support. Having studied logistics, Michiel has experience working for the Dutch Department of Defense and in automation system simulation and analysis. Before joining Swisslog, he spent five years optimising warehouse operations and IT systems for a small veterinarian pharma wholesaler.
spacer
Michiel Veenman
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

BioIVT to Focus on the Application of In Vitro Hepatocyte Models in Toxicology Research at the North American ISSX Meeting

BioIVT, a leading provider of research models and services for drug development, today announced that it will be participating in several sessions at the 22nd North American International Society for the Study of Xenobiotics (ISSX) Meeting. This conference will be held from July 15-19 at the Palais des congrès de Montréal in Montréal, Canada.
More info >>

White Papers

Tabletability, Compactability, and Compressibilty: What’s the Difference?

Natoli Engineering Company, Inc.

To patients and consumers, tablets are a simple and convenient dosage form. But the science behind compressing a block of particles or granules into a single tablet can be complicated. That’s where common compression studies can help. This article explains how to develop tabletability, compactibility, and compressibility profiles.
More info >>

 
Industry Events

BioPharm America 2018

5-6 September 2018, Hynes Convention Center

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement